Acute Myocardial Infarction after Switching from Warfarin to Dabigatran
Dabigatran etexilate is a recently approved direct thrombin inhibitor (DTI), which is superior to warfarin in the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF). However, dabigatran use is associated with an increased risk of myocardial infarction (MI) compared...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oman Medical Specialty Board
2015-01-01
|
| Saila: | Oman Medical Journal |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.omjournal.org/fultext_PDF.aspx?DetailsID=600&type=fultext |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|